Myocardial ischaemia can precipitate fatal arrhythmia, the leading cau
se of mortality in the western world. During ischaemia, cardiac myocyt
es swell rapidly. Such changes in cell volume radically alter the elec
trophysiology of these cells. Ischaemia also alters the potency of ant
iarrhythmic drugs, with the effectiveness of some antiarrhythmics bein
g diminished. Conversely, the idea I antiarrhythmic would be 'switched
on' by ischaemia. As well as making the drug more potent, this would
minimize unwanted side-effects by targeting diseased tissue alone. In
this article, Anthony Wright and Sian Rees discuss possible strategies
for developing 'ischaemia-selective' antiarrhythmics. To date, resear
ch has focused on potentiation of antiarrhythmic action by membrane de
polarization, as occurs during ischaemia. The authors suggest that cel
l swelling alters drug efficacy and propose that this could represent
a new way of targeting ischaemia.